Probably not because if the primary endpoint isn't
Post# of 148173
(Total Views: 499)
Posted On: 02/17/2021 7:59:25 AM
Probably not because if the primary endpoint isn't a slam dunk it will take longer to come to conclusions about secondary endpoints because those endpoints generated a LOT more data. Plus they could decide to not consider the trial completed until after 48 days. So no material decision may have been made yet.
I still think a clear cut primary endpoint benefit could be on the table and that the delay could easily be a result of data lock taking longer than expected. The trial very likely had over 100,000 data points, probably well over that amount, that had to be processed before being locked.
I still think a clear cut primary endpoint benefit could be on the table and that the delay could easily be a result of data lock taking longer than expected. The trial very likely had over 100,000 data points, probably well over that amount, that had to be processed before being locked.
(1)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼